Antibody Industry, April 2015 Market Reports from Top Publishers

You might be interested in: Diagnostics, in Vitro Diagnostic Reagent, Drug, In Vitro Instrument, Flow Cytometry, Biosimilar, Monoclonal Antibody, Vaccine, Pharmaceutical, Diagnostic Test, Diagnostic, Drug Delivery, Oncology, Blood Supply, Biomarker, Manufacturing, Therapeutics, Therapy, Tissue, Anti-infective.


 
1-10 of about 200 reports for Antibody

Purchase Reports From Reputable Market Research Publishers

Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

  • $ 1 716
  • Industry report
  • April 2015
  • by La Merie Publishing

Competitor Analysis: Therapeutic Antibodies 2015: Biosimilars & Biosuperiors This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competito ...

The 2016-2021 World Outlook for Monoclonal Antibody (MAb)-Based Products

The 2016-2021 World Outlook for Monoclonal Antibody (MAb)-Based Products

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for Monoclonal Antibody (MAb)-based products across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential ...

The 2016-2021 World Outlook for AntiCD20 Monoclonal Antibodies

The 2016-2021 World Outlook for AntiCD20 Monoclonal Antibodies

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for AntiCD20 Monoclonal antibodies across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, & Others

Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, & Others

  • $ 3 500
  • Industry report
  • April 2015
  • by Kelly Scientific Publications

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell ...

The 2016-2021 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products

The 2016-2021 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for therapeutic Monoclonal Antibody (Mab)-based products across more than 200 countries. For each year reported, estimates are given for the latent demand, ...

Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux

Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux

  • $ 330
  • Industry report
  • March 2015
  • by La Merie Publishing

Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux This Competitive Intelligence Report about EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux provides ...

Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab

Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab

  • $ 396
  • Industry report
  • March 2015
  • by La Merie Publishing

Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab This Competitive Intelligence Report about CD20 Antibodies 2015- Biosimilars and Biosuperiors of Rituximab provides ...

Competitor Analysis: TNF Antibodies 2015– Biosimilars and Biosuperiors of Humira, Remicade and Enbrel

Competitor Analysis: TNF Antibodies 2015– Biosimilars and Biosuperiors of Humira, Remicade and Enbrel

  • $ 660
  • Industry report
  • March 2015
  • by La Merie Publishing

Competitor Analysis: TNF Antibodies 2015– Biosimilars and Biosuperiors of Humira, Remicade and Enbrel The present Competitive Intelligence report about TNF Antibodies 2015– Biosimilars and Biosuperiors ...

4-Antibody AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

4-Antibody AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2015
  • by Global Data

Summary 4-Antibody AG (4-Antibody) is a biopharmaceutical company. The company develops fully-human antibody drug-discovery and optimization technology platform for discovery and development of therapeutic ...

AC Immune SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

AC Immune SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2015
  • by Global Data

Summary AC Immune SA (AC Immune) is a biopharmaceutical company. The company discovers and develops drugs for Alzheimer’s disease and other conformational diseases. It develops new therapeutics including ...

About 10 000 reports for Antibody

Download Unlimited Documents from Trusted Public Sources

Antibody Industry in the US

  • February 2015
    22 pages
  • Antibody  

    Cancer  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.